Zhang Y, Chen Z, Chen G, Huang Y, et al. The Design for a Phase II, Randomized, Multicenter Study of CtDNA-Guided Treatment With Furmonertinib Combined Therapy or Furmonertinib Alone for Untreated Advanced EGFR Mutant Non-small-cell Lung Cancer Patients: The FOCUS-C Study. Clin Lung Cancer 2024 Jun 10:S1525-7304(24)00111.
PMID: 38945800